Concentra Group Holdings Parent

Valuation Analysis

About the Company

Concentra Group Holdings Parent en bref

Concentra Group Holdings Parent (CON) is currently trading at 24,91 € with a market capitalization of 3,2 Md €. The trailing P/E ratio stands at 20.54x, with a forward P/E of 16.81x. The 52-week range spans from 16,19 € to 25,19 €; the current price is 1.1% below the yearly high. Year-over-year revenue growth stands at +13.7%. The net profit margin stands at 7.97%.

💰 Dividende

Concentra Group Holdings Parent pays an annual dividend of 0,22 € per share, representing a yield of 0.88%. The payout ratio stands at 17.99%.

📊 Avis des analystes

8 analystes évaluent Concentra Group Holdings Parent (CON) au consensus : Achat Fort. L'objectif de cours moyen est de 27,49 €, soit un potentiel de +10.31% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 24,43 € à 31,42 €.

Concentra Group Holdings Parent : la thèse d'investissement en détail

Concentra Group Holdings Parent (CON) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 13.7% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 29.4% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. Return on equity of 47% places management among the most capital-efficient operators in the public market — every euro of shareholder capital is working hard.

Le scénario baissier

The debt-to-equity ratio of 467.74% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn.

À surveiller

• The forward P/E of 16.81x is meaningfully below the trailing 20.54x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 96.9% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Concentra Group Holdings Parent?

Compare top-rated brokers — low fees, trusted providers, fully regulated.